301228.SZ
实朴检测
SZSE · M 科研服务 · CN
CNY 59.78
+1.63%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 369.3M | 398.4M | 442.1M | 373.8M | 351.5M |
| Cost of Revenue | 303.0M | 317.4M | 320.3M | 297.3M | 234.0M |
| Gross Profit | 66.3M | 80.9M | 121.8M | 76.5M | 117.5M |
| Operating Expenses | |||||
| R&D Expense | 23.9M | 27.1M | 31.6M | 37.2M | 41.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 42.5M | 44.6M | 50.6M | 43.5M | 37.8M |
| Selling & Marketing Expense | 47.6M | 49.5M | 54.0M | 57.4M | 41.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 117.4M | 124.4M | 139.3M | 140.1M | 123.5M |
| Cost and Expenses | 420.4M | 441.8M | 459.6M | 437.3M | 357.5M |
| Operating Income (EBIT) | (47.9M) | (51.0M) | (63.9M) | (103.4M) | (23.9M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (46.3M) | (51.2M) | (64.2M) | (104.7M) | (24.7M) |
| Income Tax Expense | 12.8M | 10.5M | (8.7M) | (16.7M) | (9.0M) |
| Bottom Line | |||||
| Net Income | (64.3M) | (68.0M) | (65.8M) | (93.5M) | (18.0M) |
| Earnings from Cont. Ops | (59.1M) | (61.8M) | (55.5M) | (88.0M) | (15.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (64.3M) | (68.0M) | (65.8M) | (93.5M) | (18.0M) |
| Per Share | |||||
| Basic EPS | (CN¥0.55) | (CN¥0.58) | (CN¥0.56) | (CN¥0.78) | (CN¥0.15) |
| Diluted EPS | (CN¥0.55) | (CN¥0.58) | (CN¥0.56) | (CN¥0.78) | (CN¥0.15) |
| Revenue Per Share | CN¥3.13 | CN¥3.40 | CN¥3.76 | CN¥3.12 | CN¥2.94 |
| Shares | |||||
| Basic Shares Outstanding | 118.1M | 117.2M | 117.5M | 119.9M | 119.7M |
| Diluted Shares Outstanding | 118.1M | 117.2M | 117.5M | 119.9M | 119.7M |
| Profitability Metrics | |||||
| EBITDA | — | (9.0M) | (14.7M) | (43.4M) | 29.2M |
| D&A | — | 42.0M | 49.2M | 60.0M | 53.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026